COMMUNIQUÉS West-GlobeNewswire

Freeline to Present New Data on its Gaucher and Parkinson’s Disease Programs at the American Society of Gene and Cell Therapy (ASGCT) 27th Annual Meeting

24/04/2024 - 22:00

Late-breaking oral presentation on results from Phase 1/2 study of FLT201 in Gaucher disease Poster presentation to highlight Freeline’s GBA1 Parkinson’s disease research program LONDON, April 24, 2024 (GLOBE NEWSWIRE [...]

Mural Oncology Announces Upcoming Presentation at 2024 American Society of Clinical Oncology (ASCO) Annual Meeting

24/04/2024 - 22:00

WALTHAM, Mass. and DUBLIN, Ireland, April 24, 2024 (GLOBE NEWSWIRE) -- Mural Oncology plc (Nasdaq: MURA), a clinical-stage immuno-oncology company developing novel, investigational engineered cytokine therapies designed [...]

Madrigal Statement on the Passing of Dr. Stephen Harrison

24/04/2024 - 22:00

CONSHOHOCKEN, Pa., April 24, 2024 (GLOBE NEWSWIRE) -- The Madrigal team is shocked and saddened to learn of the passing of Dr. Stephen Harrison. We offer our deepest condolences to Stephen’s family for their loss. [...]

Cytokinetics to Announce First Quarter Results on May 8, 2024

24/04/2024 - 22:00

SOUTH SAN FRANCISCO, Calif., April 24, 2024 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that it is scheduled to report first quarter results on May 8, 2024 at 4:00 PM Eastern Time. [...]

InnovAge Launches PACE Center in Los Angeles, Helping Seniors Live Independently with High-Quality Care

24/04/2024 - 22:00

Crenshaw Center Spotlights Impact of Participant-Centered, Coordinated Senior Care at No Cost to Eligible Seniors LOS ANGELES, April 24, 2024 (GLOBE NEWSWIRE) -- InnovAge Holding Corp. (“InnovAge”) (Nasdaq: INNV), the [...]

Amarin Applauds HealthyWomen’s Citizen’s Petition Urging FDA To Take Further Action On Fenofibrate Prescribing in Patients at Risk of Cardiovascular Event

24/04/2024 - 20:00

Citizen Petition Spotlights Risks for Patients on Drug Proven to Have No Benefit in Improving Cardiovascular Outcomes and Need for Urgent Regulatory Action to Protect Patients DUBLIN, Ireland and BRIDGEWATER, N.J., [...]

SpringWorks Therapeutics Announces Abstracts Accepted for Presentation at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting

24/04/2024 - 19:31

– Results from Phase 2b ReNeu trial of mirdametinib in NF1-PN accepted for oral presentation – – Additional data from the Phase 3 DeFi trial of OGSIVEO ® (nirogacestat) in adults with desmoid tumors also accepted for [...]

LTC ACO Welcomes New Chief Operating Officer

24/04/2024 - 19:06

Country’s First Long-term Care Accountable Care Organization Appoints Michele Fronckiewicz to Executive Leadership Team KENNETT SQUARE, Pa., April 24, 2024 (GLOBE NEWSWIRE) -- LTC ACO , the first Accountable Care [...]

Virbac : Public release of Virbac Annual Report at 31 December 2023 (ESEF format)

24/04/2024 - 18:00

Public release of Virbac Annual Report at 31 December 2023 (ESEF format). The Group released and filed its 2023 Annual Report with the French “Autorité des marchés financiers”. The document is also available on the [...]

Virbac : Communiqué de mise à disposition du Rapport Annuel au format ESEF au 31 décembre 2023

24/04/2024 - 18:00

Communiqué de mise à disposition du Rapport Annuel au format ESEF au 31 décembre 2023. Le Groupe annonce avoir mis à la disposition du public et déposé auprès de l’Autorité des marchés financiers son Rapport Annuel au [...]

Basilea shareholders approve all proposals of the board of directors at the annual general meeting

24/04/2024 - 18:00

Allschwil, Switzerland, April 24, 2024 Basilea Pharmaceutica Ltd, Allschwil (SIX: BSLN), a commercial-stage biopharmaceutical company committed to meeting the needs of patients with severe bacterial and fungal [...]

BrightInsight Recognized Among Newsweek’s World’s Best Digital Health Companies 2024 List

24/04/2024 - 17:59

SAN JOSE, Calif., April 24, 2024 (GLOBE NEWSWIRE) -- BrightInsight, Inc . , the trusted partner and de-facto platform driving value for top biopharma compliant digital health solutions, is thrilled to announce it has [...]

TScan Therapeutics Announces Exercise of Underwriters' Option to Purchase Additional Shares

24/04/2024 - 17:03

WALTHAM, Mass., April 24, 2024 (GLOBE NEWSWIRE) -- TScan Therapeutics, Inc. (Nasdaq: TCRX), a clinical-stage biopharmaceutical company focused on the development of T cell receptor (TCR)-engineered T cell therapies (TCR [...]

NMDP to Present New Stem Cell Transplantation Data at the 2024 American Society of Clinical Oncology Annual Meeting

24/04/2024 - 16:43

MINNEAPOLIS, April 24, 2024 (GLOBE NEWSWIRE) -- NMDP℠, a global nonprofit leader in cell therapy, and CIBMTR ® (Center for International Blood and Marrow Transplant Research ® ) will present new data on hematopoietic [...]

Invitation to the presentation of ALK’s first quarter results on Friday 3 May 2024

24/04/2024 - 16:35

ALK ( ALKB:DC / OMX: ALK B / AKBLF ) will publish its first quarter results in the morning of 3 May 2024. Later same day, the company will host a presentation for investors and analysts at 12:30 CET, where ALK’s [...]

BioXcel Therapeutics Announces Late-Breaking Abstract on Preliminary Findings from Phase 2 Investigator-Sponsored Trial of BXCL701 and KEYTRUDA® in Metastatic Pancreatic Ductal Adenocarcinoma (PDAC) Selected for Presentation at 2024 ASCO Annual Meeting

24/04/2024 - 16:30

Poster presentation scheduled for June 1, 2024, 1:30-4:30 PM CT /2:30-5:30 PM ET Trial being led by Georgetown University’s Lombardi Comprehensive Cancer Center NEW HAVEN, Conn., April 24, 2024 (GLOBE NEWSWIRE) -- [...]

Global COVID-19 Memorial Will Honor Pandemic Frontline & Essential Workers

24/04/2024 - 16:18

CHICAGO, April 24, 2024 (GLOBE NEWSWIRE) -- A monument park and website honoring medical frontline and essential workers worldwide who risked their lives during the COVID-19 pandemic will break ground this summer in [...]

Ultimovacs Announces Poster Presentation at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting

24/04/2024 - 16:15

NON-REGULATORY PRESS RELEASE Oslo, April 24, 2024: Ultimovacs ASA (“Ultimovacs”) (OSE ULTI), a clinical-stage biotechnology company developing immunotherapeutic cancer vaccines, today announces that the data from the [...]

Cullinan Therapeutics to Present Clinical Data from Phase 1 Study Evaluating Novel Anti-MICA/B Antibody, CLN-619, as Monotherapy and in Combination with a Checkpoint Inhibitor in Patients with Advanced Solid Tumors at ASCO 2024

24/04/2024 - 16:09

CAMBRIDGE, Mass., April 24, 2024 (GLOBE NEWSWIRE) -- Cullinan Therapeutics, Inc. (Nasdaq: CGEM), a biopharmaceutical company focused on modality-agnostic targeted therapies, today announced that clinical data from its [...]